Expansion financing Positron recently secured equity financing of 2 million and an 8 million capital raise in 2025, signaling available runway to accelerate market expansion and scale sales efforts for their PET and PET-CT imaging systems.

Strategic partnerships Partnership with MedAxiom positions Positron to access cardiovascular leadership networks, education programs, and operational insights, creating a channel for coordinated sales outreach to cardiology and nuclear medicine groups.

Product roadmap Launch of Affinity 4D PET-CT with LYSO crystals, AI-based motion monitoring, and dose reduction enhancements indicates a compelling upgrade path and cross-sell opportunities to existing oncology and cardiac imaging customers.

Awarded credibility Recent Innovation Award in PET-CT Imaging reinforces market credibility and differentiates Positron’s technology, supporting sales conversations with potential customers seeking advanced molecular imaging capabilities.

Market focus Clear emphasis on cardiac PET imaging with expansion into oncology imaging suggests cross-domain opportunities to upsell integrated PET-CT solutions to nuclear medicine clinics and hospitals expanding molecular imaging portfolios.